Metabolism dysfunction research hub

A study to see how a single increasing dose of the oral drug AD-700 affects the ability of a CT scan to detect activated brown fat in healthy people

This early-stage study is testing an experimental medicine called AD-700 in healthy men aged 18 and over. Researchers want to see if a single dose can activate brown fat—a type of fat that burns energy—and whether this activity can be clearly seen on a CT scan.